EPISODE · Jun 22, 2026 · 11 MIN
ASCO 2026 Plenary: SARC-041
from Two Onc Docs
This week’s episode will be focusing on an ASCO 2026 Plenary abstract, SARC 041. SARC041 is the first positive phase 3 randomized controlled trial of a CDK4/6 inhibitor in advanced dedifferentiated liposarcoma (DDLPS), demonstrating that abemaciclib significantly improves progression-free survival compared to placebo.
Embed this episode
NOW PLAYING
ASCO 2026 Plenary: SARC-041
0:00
11:34
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Two Onc Docs?
This episode is 11 minutes long.
When was this Two Onc Docs episode published?
This episode was published on June 22, 2026.
Can I download this Two Onc Docs episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!